Ignite Creation Date:
2024-05-06 @ 5:39 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05388929
Status:
RECRUITING
Last Update Posted:
2024-01-18
First Post:
2022-05-19
Brief Title:
Methocarbamol in Ventral and Inguinal HR
Sponsor:
Prisma Health-Upstate
Organization:
Prisma Health-Upstate
Study Overview
Official Title:
Addition of Methocarbamol to Postoperative Multimodal Analgesic Regimen A Prospective Randomized Pilot Study
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to gather information on methocarbamol as a pain management treatment for ventral or inguinal hernia repair
Methocarbamol has been part of the pain management treatment for both inpatient and outpatient procedures at Prisma Health This study will compare the outcomes of patients who receive methocarbamol those who receive the standard opioid pain management treatment and those who receive methocarbamol plus the standard opioid pain management treatment
Participants will be randomized into one of the study groups listed below
Primary ventral hernia repair or inguinal hernia repair
Group 1 standard opioid after surgery Group 2 methocarbamol after surgery
Open or robotic ventral hernia repair outpatient
Group 1 standard opioid after surgery Group 2 standard opioid plus methocarbamol after surgery
Open or robotic ventral hernia repair inpatient
Group 1 standard opioid at discharge Group 2 standard opioid plus methocarbamol at discharge
A total of 200 participants will be included in the study
Participation will last for about 30 days after surgery
Methocarbamol has been part of the pain management treatment for both inpatient and outpatient procedures at Prisma Health This study will compare the outcomes of patients who receive methocarbamol those who receive the standard opioid pain management treatment and those who receive methocarbamol plus the standard opioid pain management treatment
Participants will be randomized into one of the study groups listed below
Primary ventral hernia repair or inguinal hernia repair
Group 1 standard opioid after surgery Group 2 methocarbamol after surgery
Open or robotic ventral hernia repair outpatient
Group 1 standard opioid after surgery Group 2 standard opioid plus methocarbamol after surgery
Open or robotic ventral hernia repair inpatient
Group 1 standard opioid at discharge Group 2 standard opioid plus methocarbamol at discharge
A total of 200 participants will be included in the study
Participation will last for about 30 days after surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None